BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1174081)

  • 1. [Results of some clinical-pharmacological studies on ambroxol (NA 872)].
    Renovanz VK
    Arzneimittelforschung; 1975 Apr; 25(4):646-52. PubMed ID: 1174081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of a clinical trial with ambroxol as to postoperative therapy of bronchitis (author's transl)].
    Kranicke R
    Arzneimittelforschung; 1978; 28(5a):934-5. PubMed ID: 581994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with ambroxol syrup (author's transl)].
    Göbel P; Rensch H
    Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
    Prabhu Shankar S; Chandrashekharan S; Bolmall CS; Baliga V
    J Indian Med Assoc; 2010 May; 108(5):313-4, 316-8, 320. PubMed ID: 21121410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)].
    Curti PC; Renovanz HD
    Arzneimittelforschung; 1978; 28(5a):922-5. PubMed ID: 581991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A derivative of benzyl-amine in the therapy of respiratory diseases in children].
    Gambi R; Ongaro F; Paoli R; Russo U
    Minerva Med; 1969 Sep; 60(76):3575-9. PubMed ID: 5823753
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis].
    Michnar M; Milanowski J
    Pneumonol Alergol Pol; 1996; 64 Suppl 1():90-6. PubMed ID: 9190245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The short-term clinical evaluation of bromhexine in chronic bronchitis.
    Palmer KN
    Scand J Respir Dis Suppl; 1974; 90():65-8. PubMed ID: 4618375
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
    Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
    Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
    Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
    Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhalation therapy with the new antisecretory drug ambroxol (metabolite VIII of bromhexine) in otorhinolaryngology].
    Hoffmann H
    Arzneimittelforschung; 1978; 28(5a):931-3. PubMed ID: 581993
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
    Siergiejko Z; Obrzut D; Rogalewska A
    Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of therapeutic effect of 2 application forms of a combination of N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium-chloride and sulfanilamidopyrimidine. A widespread mutual test].
    Oligschläger G
    Arzneimittelforschung; 1969 Oct; 19(10):1710-7. PubMed ID: 5395373
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of ucb 3983 in pediatric (author's transl)].
    Goffart P
    Acta Paediatr Belg; 1973; 27(4):257-62. PubMed ID: 4358847
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Ercillo L; Mollica G
    Minerva Med; 1969 Sep; 60(76):3604-6. PubMed ID: 5823758
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of new mucolytic agent in bronchopulmonary pathology in children].
    Spacagna G
    Minerva Pediatr; 1978 Aug; 30(15):1271-6. PubMed ID: 703706
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled trial of ambroxol in chronic bronchitis.
    Guyatt GH; Townsend M; Kazim F; Newhouse MT
    Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.